ARCHIVES

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

1978-79 Budgets By Program Areas

June 3, 1977

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978